1. 22LBA Activity of PD-1 blockade with pembrolizumab as first systemic therapy in patients with advanced Merkel cell carcinoma. Issue 3 (September 2015) Authors: Nghiem, P.; Bhatia, S.; Daud, A.; Friedlander, P.; Kluger, H.; Kohrt, H.; Kudchadkar, R.; Lipson, E.; Lundgren, L.; Margolin, K.; Reddy, S.; Shantha, E.; Sharfman, W.; Sharon, E.; Thompson, J.; Topalian, S.; Cheever, M. Journal: European journal of cancer Issue: Volume 51:Issue 3(2015:Feb.) Page Start: S720 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3340 Treatment beyond progression in advanced BRAF-mutated melanoma with vemurafenib and cobimetinib: Results from the BRIM7 trial. (September 2015) Authors: Lewis, K.; Ribas, A.; Gonzalez, R.; Hamid, O.; Daud, A.; Puzanov, I.; Hsu, J.; Choong, N.; Koralek, D.; McArthur, G. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S679 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 504 Intratumoral delivery of Interleukin-12 DNA via in vivo electroporation leads to regression of injected and non-injected tumors in Merkel cell carcinoma: Final Results of a phase 2 study. (September 2015) Authors: Bhatia, S.; Iyer, J.; Ibrani, D.; Blom, A.; Byrd, D.; Parvathaneni, U.; Diep, T.; Le, M.H.; Pierce, R.H.; Heller, R.; Daud, A.; Nghiem, P. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Evaluation of efficiency and quality of the multi-disciplinary team handover process in a mother and baby inpatient setting. (13th April 2021) Authors: Daud, A.; Kesete, B.; Sriranjan, S.; Britton, E.; Steel, C.; Lewin, J. Journal: European psychiatry Issue: Volume 64:Supplement 1(2021) Page Start: S500 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P0116 Updated clinical efficacy of the anti-PD-1 monoclonal antibody pembrolizumab (MK-3475) in 411 patients with melanoma. (July 2015) Authors: Ribas, A.; Wolchok, J.D.; Robert, C.; Kefford, R.; Hamid, O.; Daud, A.; Hwu, W-J.; Weber, J.S.; Joshua, A.M.; Gangadhar, T.C.; Patnaik, A.; Hersey, P.; Dronca, R.; Zarour, H.; Gergich, K.; Lindia, J.A.; Giannotti, M.; Li, X.N.; Ebbinghaus, S.; Kang, S.P. Journal: European journal of cancer Issue: Volume 51(2015)Supplement 2 Page Start: e24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Retrospective study of the incidence of sarcoidosis-like reaction in patients treated with immunotherapy. Issue 2 (February 2023) Authors: Li, Y.; Flavell, R.R.; Juarez, R.; Chow, M.; Wu, C.; Tsai, K.; Daud, A.; Behr, S.C. Journal: Clinical radiology Issue: Volume 78:Issue 2(2023) Page Start: e131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The association of preoperative blood markers with postoperative readmissions following arthroplasty. (2021) Authors: Khoshbin, A.; Hoit, G.; Nowak, L. L.; Daud, A.; Steiner, M.; Juni, P.; Ravi, B.; Atrey, A. Journal: Bone & joint open Issue: Volume 2:Number 6(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗